These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15464387)

  • 1. Radiolabeled choline as a proliferation marker: comparison with radiolabeled acetate.
    Yoshimoto M; Waki A; Obata A; Furukawa T; Yonekura Y; Fujibayashi Y
    Nucl Med Biol; 2004 Oct; 31(7):859-65. PubMed ID: 15464387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hypoxia on the uptake of [methyl-3H]choline, [1-14C] acetate and [18F]FDG in cultured prostate cancer cells.
    Hara T; Bansal A; DeGrado TR
    Nucl Med Biol; 2006 Nov; 33(8):977-84. PubMed ID: 17127170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and preclinical evaluation of the choline transport tracer deshydroxy-[18F]fluorocholine ([18F]dOC).
    Henriksen G; Herz M; Hauser A; Schwaiger M; Wester HJ
    Nucl Med Biol; 2004 Oct; 31(7):851-8. PubMed ID: 15464386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of radiolabeled choline and ethanolamine as probe for cancer detection.
    Mintz A; Wang L; Ponde DE
    Cancer Biol Ther; 2008 May; 7(5):742-7. PubMed ID: 18296919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 11C/ 18F-choline PET or 11C/18F-acetate PET in prostate cancer: may a choice be recommended?
    Nanni C; Castellucci P; Farsad M; Rubello D; Fanti S
    Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1704-5. PubMed ID: 17619877
    [No Abstract]   [Full Text] [Related]  

  • 6. Application of metabolic PET imaging in radiation oncology.
    Zhu A; Marcus DM; Shu HK; Shim H
    Radiat Res; 2012 Apr; 177(4):436-48. PubMed ID: 22339451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer.
    Breeuwsma AJ; Pruim J; Jongen MM; Suurmeijer AJ; Vaalburg W; Nijman RJ; de Jong IJ
    Eur J Nucl Med Mol Imaging; 2005 Jun; 32(6):668-73. PubMed ID: 15765234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-11C-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer.
    Vāvere AL; Kridel SJ; Wheeler FB; Lewis JS
    J Nucl Med; 2008 Feb; 49(2):327-34. PubMed ID: 18199615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ROLE OF KINETIC PERFORMANCE OF PSA IN SELECTION OF THE PATIENTS FOR CONDUCTION OF 11C-CHOLINE PET/CT AIMED TO REVEAL LOCAL RECURRENCES OF PROSTATE CANCER].
    Rybalov MA; De Iong IY; Breusma AI; Al'-Shukri SKh; Borovets SY
    Vestn Khir Im I I Grek; 2015; 174(6):25-8. PubMed ID: 27066654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging lipid synthesis in hepatocellular carcinoma with [methyl-11c]choline: correlation with in vivo metabolic studies.
    Kuang Y; Salem N; Tian H; Kolthammer JA; Corn DJ; Wu C; Wang F; Wang Y; Lee Z
    J Nucl Med; 2011 Jan; 52(1):98-106. PubMed ID: 21149484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 2-methoxyestradiol on proliferation, apoptosis and PET-tracer uptake in human prostate cancer cell aggregates.
    Davoodpour P; Bergström M; Landström M
    Nucl Med Biol; 2004 Oct; 31(7):867-74. PubMed ID: 15464388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [methyl-3H]Choline incorporation into MCF7 tumour cells: correlation with proliferation.
    Al-Saeedi F; Welch AE; Smith TA
    Eur J Nucl Med Mol Imaging; 2005 Jun; 32(6):660-7. PubMed ID: 15660258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [11C]Choline as a potential PET marker for imaging of breast cancer athymic mice.
    Zheng QH; Stone KL; Mock BH; Miller KD; Fei X; Liu X; Wang JQ; Glick-Wilson BE; Sledge GW; Hutchins GD
    Nucl Med Biol; 2002 Nov; 29(8):803-7. PubMed ID: 12453589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ¹¹C-acetate PET/CT imaging: physiologic uptake, variants, and pitfalls.
    Karanikas G; Beheshti M
    PET Clin; 2014 Jul; 9(3):339-44. PubMed ID: 25030397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferation markers for the differential diagnosis of tumor and inflammation.
    van Waarde A; Elsinga PH
    Curr Pharm Des; 2008; 14(31):3326-339. PubMed ID: 19075707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is 11C-choline the most appropriate tracer for prostate cancer? For.
    Fazio F; Picchio M; Messa C
    Eur J Nucl Med Mol Imaging; 2004 May; 31(5):753-6. PubMed ID: 15060753
    [No Abstract]   [Full Text] [Related]  

  • 17. Is 11C-choline the most appropriate tracer for prostate cancer? Against.
    Zöphel K; Kotzerke J
    Eur J Nucl Med Mol Imaging; 2004 May; 31(5):756-9. PubMed ID: 15060754
    [No Abstract]   [Full Text] [Related]  

  • 18. Value of 11C-choline PET/CT for lung cancer diagnosis and the relation between choline metabolism and proliferation of cancer cells.
    Li M; Peng Z; Liu Q; Sun J; Yao S; Liu Q
    Oncol Rep; 2013 Jan; 29(1):205-11. PubMed ID: 23124523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of deuterated 18F- and 11C-labeled choline analogs for cancer detection by positron emission tomography.
    Witney TH; Alam IS; Turton DR; Smith G; Carroll L; Brickute D; Twyman FJ; Nguyen QD; Tomasi G; Awais RO; Aboagye EO
    Clin Cancer Res; 2012 Feb; 18(4):1063-72. PubMed ID: 22235095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pro and contra: 11C choline PET in diagnosis of prostate cancer].
    Kotzerke J; Zöphel K; Salomon G; Graefen M; Heidenreich A
    Aktuelle Urol; 2007 May; 38(3):189-94. PubMed ID: 17566231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.